Table 2. – Perioperative data.
| Females (n=321) | Males (n=1,035) | p-value | |
|---|---|---|---|
| Operative duration, min | 158.7±5.2 | 159.7±4.9 | <0.01 |
| Number of grafts | 2.1±1.0 | 2.1±0.9 | 0.47 |
| Venous grafts | |||
| 0 | 96 (29.9%) | 317 (30.6%) | 0.95 |
| 1 | 176 (54.8%) | 566 (54.7%) | |
| 2 | 201 (14.8%) | 152 (14.7%) | |
| LIMA | 0.65 | ||
| 0 | 60 (18.7%) | 182 (17.6%) | |
| 1 | 261 (81.3%) | 853 (82.4%) | |
| RIMA | 0.08 | ||
| 0 | 287 (89.4%) | 957 (92.5%) | |
| 1 | 34 (10.6%) | 78 (7.5%) | |
| Radialis grafts | 0.70 | ||
| 0 | 205 (63.9%) | 673 (65.0%) | |
| 1 | 116 (36.1%) | 362 (35.0%) | |
| Postoperative length of ICU stays, days | 2.5±0.8 | 2.4±0.8 | 0.06 |
| Postoperative length of hospital stays, days | 6.8±1.8 | 6.9±1.7 | 0.51 |
| Medications at discharge | |||
| Statins | 74 (23.1%) | 287 (27.7%) | 0.10 |
| Aspirin | 278 (86.6%) | 919 (88.8%) | 0.29 |
| Thienopyridines | 56 (17.4%) | 199 (19.2%) | 0.48 |
| ACEI | 45 (14.0%) | 155 (15.0%) | 0.67 |
| ARB | 45 (14.0%) | 160 (15.5%) | 0.53 |
| β antagonist | 35 (10.9%) | 118 (11.4%) | 0.84 |
| Calcium antagonist | 201 (62.6%) | 653 (63.1%) | 0.88 |
| Nitrates | 160 (49.8%) | 475 (45.9%) | 0.22 |
LIMA: left internal mammary artery; RIMA: right internal mammary artery; ACE: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blockers.